Groprinosin - Instructions, Reviews, Application

2024 Author: Rachel Wainwright | [email protected]. Last modified: 2023-12-15 07:39

Groprinosine

Instructions for use:

1. Pharmacological action
2. Release form
3. Indications for use
4. Instructions for use and doses
5. Side effects
6. Contraindications

Groprinosine is an antiviral drug.

pharmachologic effect

Groprinosine inhibits the growth of viruses, has an immunostimulating effect.

The use of Groprinosin has a good effect on the immune system, reduces viral load, and increases the body's resistance to viruses.

There are reviews about Groprinosine, its positive effect on herpes - it promotes the accelerated production of antibodies, reduces the negative manifestations of infection, and affects the duration of remission.

The drug reaches its maximum concentration one hour after internal use.

Release form

Groprinosine is produced in tablets.

Indications for the use of Groprinosin

According to the instructions, Groprinosin is prescribed for the treatment of viral infections: acute respiratory, viral bronchitis, measles, epidemic mumps, diseases provoked by herpes, cytomegalovirus, Epstein-Barr virus, papillomavirus, for the treatment of acute, chronic viral hepatitis B.

There are good reviews about Groprinosin, its use in the treatment of infections of the respiratory, genitourinary systems, provoked by intracellular pathogens.

Instructions for use and doses

Groprinosine is for internal use only (preferably after meals). A Groprinosin tablet for children can be crushed for ease of use.

For the treatment of ARVI, adults are prescribed two tablets of the drug 3-4 r / day. For children, the daily dose is calculated based on their weight (50 mg / kg) and divided into three to four doses. In order to achieve the maximum effect, Groprinosin must be taken already when the first symptoms of the disease appear and the therapy must not be stopped for another 1-2 days. after they disappear.

For the treatment of mumps, the dosage is calculated based on the weight of the patient - 70 mc / kg. The therapy lasts 7-10 days. The drug intake is divided into 3-4 rubles.

The use of Groprinosin for viral bronchitis is carried out according to the following scheme: adults are given 2 tab. three r / day, children - 50 mg / kg (in three to four doses).

Measles treatment with the drug is carried out on the basis of the following calculation: 100 mg / kg of the patient's weight - the daily dose, which is divided by 3-4 r.

With stomatitis aphthous according to the instructions of Groprinosin, the recommended adult dose is 2 tab. 4 rubles / day.

With mononucleosis, cytomegalovirus, Groprinosin is prescribed based on body weight: 50 mg / kg (daily dose).

For the treatment of herpes of the 1st type, Groprinosin for children is prescribed at the rate of 50 mg / kg, for adults - 2 tab. 4 rubles / day.

For the treatment of type 2 herpes, two tablets are prescribed during the exacerbation (3 r / day) for 5-6 days, after which they switch to maintenance therapy - 1 tab. one r / day for 6 months.

In hepatitis B, Groprinosin is used according to the following calculation: adults - 2 tab. 3-4 r / day 2-4 weeks, after which two tablets are given one r / day (for 6 months).

For the treatment of infections of the respiratory, genitourinary systems caused by intracellular pathogens, the dose for adults is indicated in the Groprinosin instructions: Table 2. 3-4 r / day for 2-12 weeks. Groprinosine for children is prescribed based on weight: 50 mg / kg. The course of treatment lasts an average of 3 weeks.

In order to restore the positive immune status, the immunomodulatory property of the drug manifests itself, it should be taken 3-9 weeks.

Side effects

Reviews of Groprinosine are good, it is well tolerated even with prolonged therapy. Rarely, but nausea, epigastric pain, constipation, diarrhea, loss of appetite, dizziness, skin rash, arthralgia, increased transaminase levels, headaches, sleep disturbances may occur.

Contraindications

Groprinosin is not prescribed if the patient is found to be intolerant of the drug, with chronic renal failure in the terminal state, during pregnancy, lactation, with urolithiasis.

Information about the drug is generalized, provided for informational purposes only and does not replace the official instructions. Self-medication is hazardous to health!